Home
Conditions
Myeloproliferative Disorders

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,108 public trials 144 recruiting studies

Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Completed

GTI-2040 in Treating Patients With Relapsed, Refractory, or High-Risk Acute Leukemia, High-Grade Myelodysplastic Syndromes, or Refractory or Blastic Phase Chronic Myelogenous Leukemia

NCT00459212

Conditions: Acute Undifferentiated Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +40 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

PEG Interferon Alpha 2B and Low-Dose Ara-C in Early Chronic Phase CML

NCT00303290

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +12 more
Locations: The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Randomized Phase Lll Study of Imatinib Dose Optimization vs Nilotinib in CML Patients With Suboptimal Response to Imatinib

NCT00802841

Conditions: Bone Marrow Diseases, Bronchial Diseases, Bronchiolitis, +22 more
Locations: Novartis Investigative Site Caba, Buenos Aires, Argentina

Novartis Investigative Site Caba, Buenos Aires, Argentina

Novartis Investigative Site La Plata, Buenos Aires, Argentina

Novartis Investigative Site Rio Negro, Viedma, Argentina

View all 56 locations

View Trial Details

Completed

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

NCT00161187

Conditions: Adenocarcinoma, Adnexal Diseases, Blast Crisis, +151 more
Locations: Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States

View Trial Details

Completed

Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies

NCT00079391

Conditions: Bone Marrow Diseases, Bone Marrow Transplant Rejection, Chronic Disease, +28 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis

NCT00586651

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +12 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

NY Presbyterian-Cornell New York, United States

Mount Sinai School of Medicine New York, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML

NCT00085709

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations: Providence Cancer Center Anchorage, Alaska, United States

Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Fort Smith, Arkansas, United States

Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Alta Bates Summit Comprehensive Cancer Center Berkeley, California, United States

View all 279 locations

View Trial Details

Completed

A Study of Complete Molecular Response for Chronic Myeloid Leukemia in Chronic Phase Patients, Treated With Dasatinib

NCT01342679

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations: Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital Bunkyo-ku, Tokyo, Japan

View Trial Details

Completed

A Study of Dasatinib in Patients With Imatinib Resistant or Intolerant Chronic Myeloid Leukemia

NCT00866736

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +12 more
Locations: Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital Bunkyo-ku, Tokyo, Japan

View Trial Details

Completed

Pulmonary Vasculopathy Under Second-line Therapy of Chronic Myeloid Leukemia

NCT01805843

Conditions: Bone Marrow Diseases, Cardiovascular Diseases, Chronic Disease, +17 more
Locations: Medical University of Graz, Division of Pulmonology Graz, Austria

View Trial Details

Myeloproliferative Disorders

Myeloproliferative Disorders trial results

Related conditions